NO934722D0 - Amidderivater av antibiotika A 40926 - Google Patents

Amidderivater av antibiotika A 40926

Info

Publication number
NO934722D0
NO934722D0 NO934722A NO934722A NO934722D0 NO 934722 D0 NO934722 D0 NO 934722D0 NO 934722 A NO934722 A NO 934722A NO 934722 A NO934722 A NO 934722A NO 934722 D0 NO934722 D0 NO 934722D0
Authority
NO
Norway
Prior art keywords
antibiotic
amide derivatives
alkylaminocarbonyl
substituent
staplylococci
Prior art date
Application number
NO934722A
Other languages
English (en)
Other versions
NO314150B1 (no
NO934722L (no
Inventor
Adriano Malabarba
Romeo Ciabatti
Gianbattista Panzone
Alessandra Maria Marazzi
Original Assignee
Lepetit Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26128958&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO934722(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lepetit Spa filed Critical Lepetit Spa
Publication of NO934722D0 publication Critical patent/NO934722D0/no
Publication of NO934722L publication Critical patent/NO934722L/no
Publication of NO314150B1 publication Critical patent/NO314150B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/006—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure
    • C07K9/008—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure directly attached to a hetero atom of the saccharide radical, e.g. actaplanin, avoparcin, ristomycin, vancomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Cephalosporin Compounds (AREA)
  • Peptides Or Proteins (AREA)
NO19934722A 1991-07-29 1993-12-20 Amidderivater av antibiotika A-40926, fremgangsmåte for fremstilling av samme, anvendelse av samme for fremstilling av medikament samtfarmasöytisk sammensetning inneholdende samme NO314150B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP91112685 1991-07-29
EP92109906 1992-06-12
PCT/EP1992/001594 WO1993003060A1 (en) 1991-07-29 1992-07-14 Amide derivatives of antibiotic a 40926

Publications (3)

Publication Number Publication Date
NO934722D0 true NO934722D0 (no) 1993-12-20
NO934722L NO934722L (no) 1994-02-14
NO314150B1 NO314150B1 (no) 2003-02-03

Family

ID=26128958

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19934722A NO314150B1 (no) 1991-07-29 1993-12-20 Amidderivater av antibiotika A-40926, fremgangsmåte for fremstilling av samme, anvendelse av samme for fremstilling av medikament samtfarmasöytisk sammensetning inneholdende samme

Country Status (24)

Country Link
EP (2) EP0525499A1 (no)
JP (1) JP3418762B2 (no)
KR (1) KR100242682B1 (no)
AT (1) ATE125551T1 (no)
AU (1) AU666862B2 (no)
BG (1) BG61124B2 (no)
CA (1) CA2109601C (no)
CZ (1) CZ285703B6 (no)
DE (1) DE69203724T2 (no)
DK (1) DK0596929T3 (no)
ES (1) ES2075709T3 (no)
FI (1) FI112662B (no)
GR (1) GR3017897T3 (no)
HU (2) HU223946B1 (no)
IE (1) IE68420B1 (no)
IL (1) IL102623A (no)
MX (1) MX9204394A (no)
NO (1) NO314150B1 (no)
NZ (1) NZ243735A (no)
PL (1) PL171813B1 (no)
RU (1) RU2125058C1 (no)
TW (1) TW218021B (no)
UA (1) UA41283C2 (no)
WO (1) WO1993003060A1 (no)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5606036A (en) * 1991-03-27 1997-02-25 Gruppo Lepetit Spa Antibiotic A 40926 ester derivatives
US5840684A (en) * 1994-01-28 1998-11-24 Eli Lilly And Company Glycopeptide antibiotic derivatives
NZ270387A (en) * 1994-01-28 1996-11-26 Lilly Co Eli Glycopeptide antibiotic, its production and compositions thereof
US5939523A (en) * 1995-07-05 1999-08-17 Gruppo Lepetit Spa Purification of dalbaheptide antibiotics by isoelectric focusing
EP0912604B1 (en) 1996-04-23 2001-11-14 Biosearch Italia S.p.A. Improved chemical process for preparing amide derivatives of antibiotic A 40926
US6004959A (en) * 1996-05-30 1999-12-21 Hoechst Marion Roussel, Inc. Alkyloxyamino substituted fluorenones and their use as protein kinase-C inhibitors
US6392012B1 (en) 1998-12-23 2002-05-21 Advanced Medicine, Inc. Glycopeptide derivatives and pharmaceutical compositions containing the same
AR021964A1 (es) * 1998-12-23 2002-09-04 Theravance Inc Un compuesto glicopeptidico, composiciones farmaceuticas que los contienen y uso de dichos compuestos glicopeptidicos para la manufactura de un medicamento antibacteriano.
TWI275594B (en) 2001-08-24 2007-03-11 Theravance Inc Process for preparing vancomycin phosphonate derivatives
TWI312785B (en) * 2001-08-24 2009-08-01 Theravance Inc Process for preparing vancomycin derivatives
KR100478533B1 (ko) * 2002-07-30 2005-03-28 한국수력원자력 주식회사 레이저를 이용한 탈륨 동위원소 분리방법
US7119061B2 (en) * 2002-11-18 2006-10-10 Vicuron Pharmaceuticals, Inc. Dalbavancin compositions for treatment of bacterial infections
JP5519090B2 (ja) 2002-11-18 2014-06-11 ヴィキュロン ファーマシューティカルズ インコーポレイテッド 細菌感染の治療のためのダルババンシンの投与方法
US20060074014A1 (en) 2002-11-18 2006-04-06 Vicuron Pharmaceuticals Inc. Dalbavancin compositions for treatment of bacterial infections
US7521418B2 (en) 2003-05-27 2009-04-21 Theravance, Inc. Use of a polyene macrolide antifungal agent in combination with a glycopeptide antibacterial agent
EP1654036B1 (en) 2003-07-22 2007-12-26 Theravance, Inc. Use of an echinocandin antifungal agent in combination with a glycopeptide antibacterial agent
MX2007006319A (es) 2004-11-29 2007-07-25 Univ Nagoya Nat Univ Corp Derivados de monomeros de glicopeptico antibioticos.
TW200808818A (en) 2006-05-26 2008-02-16 Shionogi & Co Glycopeptide antibiotic derivatives
WO2009081958A1 (ja) 2007-12-26 2009-07-02 Shionogi & Co., Ltd. グリコペプチド抗生物質配糖化誘導体
US20240083950A1 (en) * 2021-01-11 2024-03-14 Xellia Pharmaceuticals Aps Synthesis process

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8608809D0 (en) * 1986-04-11 1986-05-14 Lepetit Spa Antibiotic
GB8726859D0 (en) * 1987-11-17 1987-12-23 Lepetit Spa 22-dechlorotei-coplanins
EP0376041B1 (en) * 1988-12-27 1996-02-28 GRUPPO LEPETIT S.p.A. C63-Amide derivatives of 34-de(acetylglucosaminyl)-34-deoxy-teicoplanins
GB2231846B (en) * 1989-05-25 1993-02-24 Hadlum Brothers Ltd A hand held carrier
JPH06503306A (ja) * 1990-12-05 1994-04-14 グルポ・レペチツト・エス・ピー・エイ テイコプラニン抗生物質の３８−デカルボキシ−３８−ヒドロキシメチル誘導体およびそれらの製造方法
KR100209971B1 (ko) * 1991-03-27 1999-07-15 클라우디오 쿼르타 항생제 a 40926 에스테르 유도체

Also Published As

Publication number Publication date
PL171813B1 (pl) 1997-06-30
RU2125058C1 (ru) 1999-01-20
AU2326292A (en) 1993-03-02
IL102623A0 (en) 1993-01-14
FI940394A0 (fi) 1994-01-26
NO314150B1 (no) 2003-02-03
TW218021B (no) 1993-12-21
EP0525499A1 (en) 1993-02-03
MX9204394A (es) 1993-01-29
NO934722L (no) 1994-02-14
KR100242682B1 (ko) 2000-02-01
DK0596929T3 (da) 1995-09-11
NZ243735A (en) 1995-01-27
ATE125551T1 (de) 1995-08-15
WO1993003060A1 (en) 1993-02-18
HU211347A9 (en) 1995-11-28
BG61124B2 (bg) 1996-11-29
FI940394A (fi) 1994-01-26
ES2075709T3 (es) 1995-10-01
HUT66080A (en) 1994-09-28
GR3017897T3 (en) 1996-01-31
EP0596929B1 (en) 1995-07-26
HU9400256D0 (en) 1994-05-30
FI112662B (fi) 2003-12-31
DE69203724T2 (de) 1996-01-18
JP3418762B2 (ja) 2003-06-23
CZ19294A3 (en) 1994-11-16
IL102623A (en) 1996-10-16
DE69203724D1 (de) 1995-08-31
CA2109601A1 (en) 1993-02-18
AU666862B2 (en) 1996-02-29
HU223946B1 (hu) 2005-03-29
CA2109601C (en) 2002-07-02
EP0596929A1 (en) 1994-05-18
UA41283C2 (uk) 2001-09-17
IE922451A1 (en) 1993-02-10
IE68420B1 (en) 1996-06-12
CZ285703B6 (cs) 1999-10-13
JPH06509347A (ja) 1994-10-20

Similar Documents

Publication Publication Date Title
NO934722L (no) Amidderivater av antibiotika A 40926
ATE282630T1 (de) Dolastatin-derivate
DE69230824D1 (de) Neue tetrapeptidderivate
ATE157368T1 (de) 6-0-methylerythromycin a-derivat
NO2006018I1 (no) Entekavir:(2-amino-1,9-dihydro-9Ä(1S,3R,4S)-4hydroksy-3-(hydroksymetyl)-2-metylencyklopentylÜ-6H-purin-6-on og hydrater derav, saerlig monohydrat
DK0582829T3 (da) 9-(Substitueret glycyl)amido-6-demethyl-6-deoxytetracycliner som antibiotiske midler
RU94013457A (ru) Амидные производные антибиотика а 40926
ES2173391T3 (es) Derivados de 2-aminobenzazepina y su uso para el tratamiento de la inmunodepresion.
DK0451547T3 (da) 1,4,8-triazacyclotridecanderivater med prolylendopeptidase inhiberende aktivitet
BG102647A (en) Acyclic nucleoside derivatives
DE69423339D1 (de) Epoxycyclohexendionderivat
ATE90685T1 (de) Disaccharidderivate.
FI963568A (fi) Peptidijohdannaisia
DE69611148D1 (de) Pyrrolo(4,3,2-de)chinolin-Derivat
ATE194621T1 (de) Pyrazolothiazolopyrimidin-derivate
EP0404104A3 (en) Angolamycin derivatives

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees